CDC42 and infection: The hypothesis was based on our earlier findings that 1.0 μM simvastatin decreases intracellular infection in part by sequestering host GTPases, including CDC42 (Horn et al., 2008), the host-directed target of ML141 (Hong et al., 2013; Surviladze et al., 2010).